Siga Technologies (SIGA) Operating Income Growth (1y) (2011 - 2025)

Siga Technologies (SIGA) Operating Income Growth (1y) (2011 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 25.63%
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -1.30%
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -319.32%
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -14.89%
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 97.23%
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 719.49%
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 21.25%
10 Siga Technologies 223.05 Mn 68.08 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -1,985.78%
Jun 30, 2025 4,130.25%
Mar 31, 2025 -120.00%
Dec 31, 2024 -37.73%
Sep 30, 2024 141.40%
Jun 30, 2024 123.28%
Mar 31, 2024 634.81%
Dec 31, 2023 5,179.92%
Sep 30, 2023 -103.05%
Jun 30, 2023 -251.05%
Mar 31, 2023 -46.52%
Dec 31, 2022 -101.92%
Sep 30, 2022 1,556.34%
Jun 30, 2022 278,548.91%
Mar 31, 2022 27.67%
Dec 31, 2021 250.80%
Sep 30, 2021 -108.95%
Jun 30, 2021 -100.00%
Mar 31, 2021 50.24%
Dec 31, 2020 872.43%